Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Total Liabilities (2019 - 2025)

Silo Pharma (SILO) has disclosed Total Liabilities for 7 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 45.34% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 45.34% year-over-year, with the annual reading at $1.3 million for FY2025, 45.34% down from the prior year.
  • Total Liabilities hit $1.3 million in Q4 2025 for Silo Pharma, down from $1.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $2.4 million in Q4 2024 to a low of $1.2 million in Q2 2022.
  • Historically, Total Liabilities has averaged $1.5 million across 5 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Total Liabilities: surged 1250.23% in 2021 and later crashed 45.34% in 2025.
  • Year by year, Total Liabilities stood at $1.4 million in 2021, then dropped by 8.81% to $1.3 million in 2022, then grew by 20.52% to $1.6 million in 2023, then surged by 51.51% to $2.4 million in 2024, then plummeted by 45.34% to $1.3 million in 2025.
  • Business Quant data shows Total Liabilities for SILO at $1.3 million in Q4 2025, $1.4 million in Q3 2025, and $1.7 million in Q2 2025.